Breaking News Instant updates and real-time market news.

PBIP

Prudential Bancorp

$11.19 /

+0.05 (+0.45%)

16:33
06/18/20
06/18
16:33
06/18/20
16:33

Prudential Bancorp approves new stock repurchase program for up to 5%

Prudential Bancorp approved the company's fourth stock repurchase program covering up to 407,000 shares or approximately 5% of its issued and outstanding shares of common stock. The company has completed its third repurchase program, repurchasing all 900,000 shares covered by the program at an average cost of approximately $13.40 per share.

TODAY'S FREE FLY STORIES

Initiation
Azek initiated with a Buy at Stifel » 04:47
07/07/20
07/07
04:47
07/07/20
04:47
AZEK

Azek

$31.59 /

-0.945 (-2.91%)

Stifel analyst John Baugh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$31.59 /

-0.945 (-2.91%)

04:40 Today B. Riley FBR
Azek initiated with a Buy at B. Riley FBR
04:39 Today William Blair
Azek initiated with an Outperform at William Blair
06/24/20 DA Davidson
AZEK initiated with a Neutral at DA Davidson
06/24/20 DA Davidson
AZEK initiated with a Neutral at DA Davidson
  • 12
    Jun
AZEK Azek
$31.59 /

-0.945 (-2.91%)

Downgrade
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo » 04:44
07/07/20
07/07
04:44
07/07/20
04:44
FHB

First Hawaiian

$16.74 /

+0.2 (+1.21%)

Wells Fargo analyst Jared…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FHB First Hawaiian
$16.74 /

+0.2 (+1.21%)

FHB First Hawaiian
$16.74 /

+0.2 (+1.21%)

06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
06/10/20 Piper Sandler
First Hawaiian assumed with a Neutral at Piper Sandler
06/08/20 BofA
BofA upgrades First Hawaiian to Buy on signs of re-opening of tourism activity
FHB First Hawaiian
$16.74 /

+0.2 (+1.21%)

Downgrade
CommScope downgraded to Market Perform from Outperform at Raymond James » 04:43
07/07/20
07/07
04:43
07/07/20
04:43
COMM

CommScope

$8.68 /

+0.28 (+3.33%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COMM CommScope
$8.68 /

+0.28 (+3.33%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
05/05/20
Fly Intel: Top five analyst initiations
05/05/20 Loop Capital
CommScope initiated with a Hold at Loop Capital
COMM CommScope
$8.68 /

+0.28 (+3.33%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

Downgrade
Moelis downgraded to Underweight from Neutral at JPMorgan » 04:42
07/07/20
07/07
04:42
07/07/20
04:42
MC

Moelis

$31.45 /

+0.74 (+2.41%)

JPMorgan analyst Kenneth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MC Moelis
$31.45 /

+0.74 (+2.41%)

04/14/20 UBS
Moelis downgraded to Sell from Neutral at UBS
03/23/20 JPMorgan
JPMorgan downgrades Moelis to Neutral on slowing M&A risk
03/23/20 JPMorgan
Moelis downgraded to Neutral from Overweight at JPMorgan
02/06/20 Buckingham
Moelis price target raised to $41 from $39 at Buckingham
MC Moelis
$31.45 /

+0.74 (+2.41%)

MC Moelis
$31.45 /

+0.74 (+2.41%)

MC Moelis
$31.45 /

+0.74 (+2.41%)

Downgrade
Cosan downgraded to Neutral from Overweight at JPMorgan » 04:42
07/07/20
07/07
04:42
07/07/20
04:42
CZZ

Cosan

$17.83 /

+2.26 (+14.52%)

JPMorgan analyst Lucas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CZZ Cosan
$17.83 /

+2.26 (+14.52%)

CZZ Cosan
$17.83 /

+2.26 (+14.52%)

05/27/20 HSBC
Cosan downgraded to Hold from Buy at HSBC
05/20/20 Goldman Sachs
Cosan downgraded to Neutral from Buy at Goldman Sachs
11/05/19 Bradesco
Cosan downgraded to Neutral from Outperform at Bradesco
10/07/19 HSBC
Cosan downgraded to Hold from Buy at HSBC
Downgrade
Fortinet downgraded to Neutral from Overweight at JPMorgan » 04:41
07/07/20
07/07
04:41
07/07/20
04:41
FTNT

Fortinet

$139.61 /

+1.18 (+0.85%)

JPMorgan analyst Sterling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTNT Fortinet
$139.61 /

+1.18 (+0.85%)

FTNT Fortinet
$139.61 /

+1.18 (+0.85%)

06/16/20 Piper Sandler
Fortinet price target raised to $146 from $125 at Piper Sandler
06/03/20 Wedbush
Fortinet price target raised to $170 from $150 at Wedbush
05/22/20 BMO Capital
Palo Alto Networks price target raised to $260 from $230 at BMO Capital
05/20/20 Oppenheimer
Fortinet price target raised to $160 from $145 at Oppenheimer
FTNT Fortinet
$139.61 /

+1.18 (+0.85%)

FTNT Fortinet
$139.61 /

+1.18 (+0.85%)

FTNT Fortinet
$139.61 /

+1.18 (+0.85%)

FTNT Fortinet
$139.61 /

+1.18 (+0.85%)

Initiation
Azek initiated with a Buy at B. Riley FBR » 04:40
07/07/20
07/07
04:40
07/07/20
04:40
AZEK

Azek

$31.59 /

-0.945 (-2.91%)

B. Riley FBR initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$31.59 /

-0.945 (-2.91%)

04:39 Today William Blair
Azek initiated with an Outperform at William Blair
06/24/20 DA Davidson
AZEK initiated with a Neutral at DA Davidson
06/24/20 DA Davidson
AZEK initiated with a Neutral at DA Davidson
  • 12
    Jun
AZEK Azek
$31.59 /

-0.945 (-2.91%)

Initiation
Azek initiated with an Outperform at William Blair » 04:39
07/07/20
07/07
04:39
07/07/20
04:39
AZEK

Azek

$31.59 /

-0.945 (-2.91%)

William Blair initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$31.59 /

-0.945 (-2.91%)

06/24/20 DA Davidson
AZEK initiated with a Neutral at DA Davidson
06/24/20 DA Davidson
AZEK initiated with a Neutral at DA Davidson
  • 12
    Jun
AZEK Azek
$31.59 /

-0.945 (-2.91%)

General news
FX Action: USD-CAD has risen to a four-day peak » 04:15
07/07/20
07/07
04:15
07/07/20
04:15

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: The dollar has settled moderately higher » 03:20
07/07/20
07/07
03:20
07/07/20
03:20

FX Update: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Asian Market Update: » 01:45
07/07/20
07/07
01:45
07/07/20
01:45

Asian Market Update:…

Asian Market Update: Treasury yields are little changed at 0.676%, after the paper erased overnight gains. In FX markets USD-JPY lifted to 107.48. The rally in stock markets that saw the NASDAQ closing at a record high yesterday run out of steam during the Asian session, but most indexes have stabilized and mainland China bourses continued to rally with officials aggressively pushing the recovery story. Elsewhere though the numbers of new Covid-19 infections has raised concerns that a second wave is gathering strength as restrictions continue to be relaxed. The RBA also mentioned the uncertain health situation as one of the reasons for ongoing cautious and while the central bank kept overall policy settings unchanged it pledged to do what it takes to maintain financial stability. Topix and Nikkei are currently down -0.45% and -0.46% respectively. The Hang Seng has lost -0.2%, but CSI 300 and ASX are posting gains of 2.3% and 0.5%. U.S. futures are mostly lower, although the NASDAQ future has managed to carve out a fractional gain. The front end WTI future meanwhile is trading at USD 40.33 per barrel.

Hot Stocks
Pintec Technology announces risk management partnership with ICBC » 21:01
07/06/20
07/06
21:01
07/06/20
21:01
PT

Pintec Technology

$1.28 /

+0.15 (+13.27%)

Pintec Technology…

Pintec Technology announced an update on its cooperation with Industrial and Commercial Bank of China. ICBC has adopted and implemented Pintec's SME risk management solutions for its micro- and small-sized lending business, "enhancing the effectiveness of its lending services for SME clients", the company states.

ShowHide Related Items >><<
PT Pintec Technology
$1.28 /

+0.15 (+13.27%)

PT Pintec Technology
$1.28 /

+0.15 (+13.27%)

Upgrade
Acadia upgraded to Buy from Hold at Stifel » 20:31
07/06/20
07/06
20:31
07/06/20
20:31
ACAD

Acadia

$53.60 /

+2.03 (+3.94%)

Stifel analyst Paul…

Stifel analyst Paul Matteis upgraded Acadia to Buy from Hold with a price target of $71, up from $41. The analyst notes that the key opinion leader feedback negates his skepticism on whether primavanserin is "that good of a drug" and is "too good to overlook" in the dementia-related psychosis, or DRP. Matteis adds that the safety argument for prescribing pimavanserin in the DRP population is also "very strong".

ShowHide Related Items >><<
ACAD Acadia
$53.60 /

+2.03 (+3.94%)

ACAD Acadia
$53.60 /

+2.03 (+3.94%)

06/24/20 Citi
Acadia risk/reward skewed to upside into depression data, says Citi
06/23/20 Jefferies
Jefferies sees high odds of positive MDD data from Acadia next month
05/27/20 Oppenheimer
Acadia price target raised to $53 from $48 at Oppenheimer
04/16/20
Fly Intel: Top five analyst initiations
ACAD Acadia
$53.60 /

+2.03 (+3.94%)

  • 18
    Sep
ACAD Acadia
$53.60 /

+2.03 (+3.94%)

ACAD Acadia
$53.60 /

+2.03 (+3.94%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
07/06/20
07/06
20:25
07/06/20
20:25
PAYX

Paychex

$77.84 /

+1.26 (+1.65%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Paychex (PAYX), consensus 60c.

ShowHide Related Items >><<
PAYX Paychex
$77.84 /

+1.26 (+1.65%)

PAYX Paychex
$77.84 /

+1.26 (+1.65%)

05/20/20 Deutsche Bank
Paychex price target lowered to $75 from $80 at Deutsche Bank
05/19/20 Jefferies
Jefferies stays on sidelines of Paychex due to near-term risks
04/29/20 Credit Suisse
TriNet price target raised to $44 from $38 at Credit Suisse
03/26/20 BMO Capital
Paychex price target lowered to $70 from $80 at BMO Capital
PAYX Paychex
$77.84 /

+1.26 (+1.65%)

Upgrade
Arthur J. Gallagher upgraded to Buy from Hold at Deutsche Bank » 20:15
07/06/20
07/06
20:15
07/06/20
20:15
AJG

Arthur J. Gallagher

$96.92 /

-0.36 (-0.37%)

Deutsche Bank analyst…

Deutsche Bank analyst Phil Stefano upgraded Arthur J. Gallagher to Buy from Hold with a $120 price target.

ShowHide Related Items >><<
AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

06/22/20 Raymond James
Arthur J. Gallagher price target raised to $110 from $85 at Raymond James
06/18/20 SunTrust
Arthur J. Gallagher price target raised to $118 from $110 at SunTrust
06/18/20 Wells Fargo
Arthur J. Gallagher price target raised to $110 from $101 at Wells Fargo
06/18/20 Deutsche Bank
Arthur J. Gallagher price target raised to $100 from $95 at Deutsche Bank
AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

Upgrade
Valmont upgraded to Buy from Hold at Stifel » 20:14
07/06/20
07/06
20:14
07/06/20
20:14
VMI

Valmont

$114.07 /

+0.25 (+0.22%)

Stifel analyst Nathan…

Stifel analyst Nathan Jones upgraded Valmont to Buy from Hold with a price target of $144, up from $128. The analyst is citing his increased confidence that execution issue from the second half of last year are in the past for the company, while the demand in its Utility Support Structures Segment and Engineered Support Structures Segment remains strong. Jones adds that Valmont's Coatings Segment will bottom in Q2 and recover, and that the outlook for its Irrigation Segment - while soft - is still better than feared. The analyst further states that with steel and zinc prices remaining low, the price-to-cost dynamic for the company looks "positive".

ShowHide Related Items >><<
VMI Valmont
$114.07 /

+0.25 (+0.22%)

VMI Valmont
$114.07 /

+0.25 (+0.22%)

04/24/20 DA Davidson
Valmont price target lowered to $125 from $145
02/23/20 Stifel
Valmont Industries downgraded to Hold from Buy at Stifel
02/21/20
Fly Intel: Top five analyst downgrades
02/21/20 DA Davidson
Valmont downgraded to Neutral from Buy at DA Davidson
VMI Valmont
$114.07 /

+0.25 (+0.22%)

Earnings
Samsung sees Q2 operating profit KRW8.10T vs. KRW6.21T consensus » 19:58
07/06/20
07/06
19:58
07/06/20
19:58
SSNLF

Samsung

$0.00 /

+ (+0.00%)

Sees Q2 revenue KRW52.0T…

Sees Q2 revenue KRW52.0T vs. KRW50.17T consensus. Consensus estimates are according to Bloomberg.

ShowHide Related Items >><<
SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/19/20 Benchmark
Benchmark says Samsung's NAND chip issues likely positive for HDD makers
04/24/20 Credit Suisse
Apple, Samsung smartphone production plans revised down, says Credit Suisse
03/12/20 KeyBanc
COVID-19 impacting iPhone supply, resulting in lower store traffic, says KeyBanc
SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

Syndicate
Tenax Therapeutics announces $8M registered direct offering » 19:55
07/06/20
07/06
19:55
07/06/20
19:55
TENX

Tenax Therapeutics

$0.91 /

+0.0028 (+0.31%)

Tenax Therapeutics…

Tenax Therapeutics announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale of 2,523,611 shares of its common stock at a purchase price of $1.02780 per share and pre-funded warrants to purchase up to 652,313 shares of common stock, at a purchase price of $1.02770 per pre-funded warrant, in a registered direct offering priced at-the-market under Nasdaq rules. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings.

ShowHide Related Items >><<
TENX Tenax Therapeutics
$0.91 /

+0.0028 (+0.31%)

Hot Stocks
Evolus gets $40M convertible note investment from Daewoong Pharmaceutical Co » 19:54
07/06/20
07/06
19:54
07/06/20
19:54
EOLS

Evolus

$5.33 /

-0.15 (-2.74%)

Evolus announced that its…

Evolus announced that its strategic partner, Daewoong Pharmaceutical Co. Ltd., will invest $40M in a five-year, unsecured, subordinated, 3% convertible note in the company at a conversion price of $13.00, which represents a 144% premium to the closing price on July 6, 2020. This investment by Daewoong will be funded prior to July 31, 2020.

ShowHide Related Items >><<
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
05/26/20 Mizuho
Evolus rally Friday has no clear explanation, says Mizuho
05/22/20 Barclays
News from Korea on Medytox has 'no implications' for Evolus, says Barclays
05/22/20 Cantor Fitzgerald
Evolus stock move likely good news, says Cantor Fitzgerald
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

  • 07
    Nov
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

Hot Stocks
Evolus discloses notice of initial determination in Allegan case » 19:53
07/06/20
07/06
19:53
07/06/20
19:53
EOLS

Evolus

$5.33 /

-0.15 (-2.74%)

Evolus announced that the…

Evolus announced that the Administrative Law Judge, or ALJ, overseeing the United States International Trade Commission case filed by Allergan and Medytox in January 2019 against Daewoong and Evolus released a Notice of Initial Determination. This non-binding initial decision by the ALJ finds a violation of Section 337 of the Tariff Act of 1930. The company states: Among the grounds on which Evolus will seek review is that this investigation represents an improper attempt to use the USITC as a means to litigate a dispute between two Korean competitors that is completely disconnected from the United States. The trade secrets asserted by Allergan and its Korean partner Medytox have never been used in the United States. The intellectual property jurisdiction of the USITC was created to protect domestic industries from improper foreign competition. Evolus will petition the full Commission to review this questionable legal maneuvering which would improperly increase the jurisdiction of the USITC beyond the Commission's mandate."

ShowHide Related Items >><<
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
05/26/20 Mizuho
Evolus rally Friday has no clear explanation, says Mizuho
05/22/20 Barclays
News from Korea on Medytox has 'no implications' for Evolus, says Barclays
05/22/20 Cantor Fitzgerald
Evolus stock move likely good news, says Cantor Fitzgerald
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

  • 07
    Nov
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

Hot Stocks
Smart Global's Penguin Computing launches new Tundra AP platform » 19:50
07/06/20
07/06
19:50
07/06/20
19:50
INTC

Intel

$59.51 /

+0.4 (+0.68%)

, SGH

Smart Global

$27.77 /

+0.74 (+2.74%)

Penguin Computing, a…

Penguin Computing, a subsidiary of SMART Global Holdings, (SGH) announced that it has released the latest addition to its highly dense Tundra supercomputing platform, Tundra AP, in partnership with Intel (INTC). The company states that "customers can now benefit from the many features of Penguin Computing's Tundra platform, including industry-leading density, greater power capacity and efficiency, improved serviceability, and room-neutral cooling via integrated direct-to-chip liquid cooling, along with the performance benefits of Intel(R) Xeon(R) Scalable 9200 series processors."

ShowHide Related Items >><<
SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 Goldman Sachs
Intel downgraded to Sell from Neutral at Goldman Sachs
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/23/20 Oppenheimer
Apple creating 'wide moat' for own ecosystem, says Oppenheimer
SGH Smart Global
$27.77 /

+0.74 (+2.74%)

06/05/20 Rosenblatt
Rosenblatt starts 'misunderstood' Smart Global at Buy
06/05/20 Rosenblatt
Smart Global initiated with a Buy at Rosenblatt
04/17/20 Barclays
Smart Global downgraded to Equal Weight on Brazil exposure at Barclays
04/17/20 Barclays
Smart Global downgraded to Equal Weight from Overweight at Barclays
SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

Downgrade
ObsEva downgraded to Market Perform from Outperform at BMO Capital » 19:47
07/06/20
07/06
19:47
07/06/20
19:47
OBSV

ObsEva

$3.25 /

-2.9 (-47.15%)

BMO Capital analyst Do…

BMO Capital analyst Do Kim downgraded ObsEva to Market Perform from Outperform with a price target of $4, down from $5, citing "mixed" Linzagolix PRIMROSE 1 results. The analyst notes that the data supports uterine fibroid use approval and his probability of success rises to 85% from 60%, but his estimates for high-dose Linzagolix+ABT use "looks similar to competitors" while being third to market. Kim also pushes out his launch estimate for the treatment by one year "to reflect filing timelines."

ShowHide Related Items >><<
OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

03/24/20 Wedbush
ObsEva price target lowered to $34 from $40 at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 after pipeline update at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 from $36 at Wedbush
12/19/19 H.C. Wainwright
ObsEva price target raised to $40 from $36 at H.C. Wainwright
OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

On The Fly
Fly Intel: After-Hours Movers » 19:08
07/06/20
07/06
19:08
07/06/20
19:08
OTIC

Otonomy

$3.19 /

+0.02 (+0.63%)

, XSPA

XpresSpa

$3.79 /

-0.2 (-5.01%)

, CEMI

Chembio Diagnostics

$4.02 /

-0.15 (-3.60%)

, GLDD

Great Lakes Dredge

$8.85 /

+0.04 (+0.45%)

, PSN

Parsons

$34.56 /

-0.37 (-1.06%)

, KINS

Kingstone Companies

$4.41 /

-0.01 (-0.23%)

, MARK

Remark Holdings

$2.61 /

+0.235 (+9.89%)

, CLLS

Cellectis

$19.04 /

+0.42 (+2.26%)

, TRIB

Trinity Biotech

$2.54 /

+0.23 (+9.96%)

, RVMD

Revolution Medicines

$29.27 /

-1.73 (-5.58%)

, PCRX

Pacira

$54.13 /

+1.93 (+3.70%)

, ARE

Alexandria Real Estate

$164.78 /

-0.08 (-0.05%)

, KMI

Kinder Morgan

$15.20 /

+0.07 (+0.46%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

06/15/20 Piper Sandler
Piper remains optimistic on Otonomy ahead of near-term clinical readouts
06/01/20 Oppenheimer
Otonomy assumed with an Outperform at Oppenheimer
05/07/20 Piper Sandler
Piper still believes in potential success of three key Otonomy programs
02/07/20 Piper Sandler
Otonomy should be bought ahead of near-term readouts, says Piper Sandler
XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

06/17/20
Fly Intel: Top five analyst downgrades
06/17/20 Craig-Hallum
Chembio Diagnostics downgraded to Hold from Buy at Craig-Hallum
06/17/20 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
06/17/20 Canaccord
Chembio Diagnostics downgraded to Hold at Canaccord
GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
KINS Kingstone Companies
$4.41 /

-0.01 (-0.23%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

06/10/20 Roth Capital
Roth checks point to Kent Services as Remark Holdings distribution partner
05/27/20 Roth Capital
Wynn video 'clearly shows' Remark AI technology in use, says Roth Capital
07/15/19 Roth Capital
Sharecare liquidity event would help capitalize Remark AI business, says Roth Capital
CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

05/12/20
Fly Intel: Top five analyst initiations
05/11/20 Baird
Cellectis initiated with an Outperform at Baird
03/06/20 Citi
Cellectis price target raised to $16 from $14 at Citi
03/06/20 Goldman Sachs
Cellectis downgraded to Sell from Neutral at Goldman Sachs
TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
03/09/20 Cowen
Revolution Medicines initiated with an Outperform at Cowen
PCRX Pacira
$54.13 /

+1.93 (+3.70%)

07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
06/30/20 SVB Leerink
Pacira price target raised to $58 from $45 at SVB Leerink
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

07/06/20 Goldman Sachs
Kinder Morgan downgraded to Sell from Neutral at Goldman Sachs
05/18/20 BofA
Plains All American, GP Holdings cut to Underperform at BofA
04/07/20 Mizuho
Kinder Morgan price target lowered to $20 from $23 at Mizuho
03/24/20 Barclays
Kinder Morgan upgraded to Overweight from Equal Weight at Barclays
TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

KINS Kingstone Companies
$4.41 /

-0.01 (-0.23%)

GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

  • 07
    Jul
  • 09
    Jul
  • 07
    May
  • 13
    Feb
  • 07
    Jan
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

Earnings
Remark Holdings reports Q1 EPS (5c) vs. (23c) last year » 19:00
07/06/20
07/06
19:00
07/06/20
19:00
MARK

Remark Holdings

$2.61 /

+0.235 (+9.89%)

CEO Kai-Shing Tao says:…

CEO Kai-Shing Tao says: "The first quarter of 2020 was one of renewed focus for Remark Holdings as our development team localized our award winning AI-solutions for the U.S. market, and improved our educational thermal scanning product in response to the ongoing COVID-19 pandemic. Our product line of high-quality, highly-effective thermal imaging solutions leverages our innovative software to provide customers with the ability to scan crowds and areas of high foot traffic for indications that certain persons may require secondary screening. We spent much of the quarter on product development and building out our U.S. sales and support team, recently showing initial success with casinos, entertainment complexes, sports venues, restaurants, hospitals and medical centers as well as other industries."

ShowHide Related Items >><<
MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

06/10/20 Roth Capital
Roth checks point to Kent Services as Remark Holdings distribution partner
05/27/20 Roth Capital
Wynn video 'clearly shows' Remark AI technology in use, says Roth Capital
07/15/19 Roth Capital
Sharecare liquidity event would help capitalize Remark AI business, says Roth Capital
MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

Hot Stocks
LGI Homes reports 2,005 home closings in Q2 » 18:49
07/06/20
07/06
18:49
07/06/20
18:49
LGIH

LGI Homes

$92.29 /

+4.39 (+4.99%)

LGI Homes announced 760…

LGI Homes announced 760 home closings in June 2020, up from 651 home closings in June 2019, representing year-over-year growth of 16.7%. In addition, the company announced record-breaking quarterly home closings of 2,005 during the second quarter of 2020 compared to 1,944 home closings in the second quarter of 2019, a 3.1% increase year-over-year. The company finished the first six months of 2020 with a total of 3,840 home closings, a 21.1% increase over 3,172 home closings during the first six months of 2019. During the month of June, the company closed its 40,000th home since commencing homebuilding operations in 2003. Eric Lipar, the company's Chief Executive Officer, noted, "Fulfilling our customers' dreams of homeownership has always been our primary motivation. June is designated as National Homeownership Month and I can think of no better way to celebrate this initiative than to announce that we closed our 40,000th home during the month of June. This is another great milestone for LGI Homes. I want to congratulate all of our employees and thank them for their dedication to making homeownership a reality for more than 40,000 families across the nation."

ShowHide Related Items >><<
LGIH LGI Homes
$92.29 /

+4.39 (+4.99%)

LGIH LGI Homes
$92.29 /

+4.39 (+4.99%)

06/11/20 JPMorgan
PulteGroup upgraded, KB downgraded as JPMorgan adjusts homebuilder ratings
06/11/20 JPMorgan
LGI Homes upgraded to Neutral from Underweight at JPMorgan
06/04/20 Wedbush
LGI Homes downgraded to Neutral at Wedbush
06/04/20 Wedbush
LGI Homes downgraded to Neutral from Outperform at Wedbush
LGIH LGI Homes
$92.29 /

+4.39 (+4.99%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.